Zydus Cadila bronchospasm drug Albuterol gets USFDA approval
This medicine is used to treat and to prevent bronchospasm.
Ahmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the US Food & Drug Administration (USFDA) to market Albuterol Tablets (US RLD: Proventil Tablets) in the strengths of 2 mg and 4 mg.Albuterol is a bronchodilator. It helps open up the airways in your lungs to make it easier to breathe. This medicine is used to treat and to...
Ahmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the US Food & Drug Administration (USFDA) to market Albuterol Tablets (US RLD: Proventil Tablets) in the strengths of 2 mg and 4 mg.
Albuterol is a bronchodilator. It helps open up the airways in your lungs to make it easier to breathe.
This medicine is used to treat and to prevent bronchospasm.
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
The group now has 310 approvals and has so far filed over 390 ANDAs since the commencement of the filing process in FY 2003-04.
Read also: Zydus Cadila Solifenacin Succinate tablets get USFDA okay to treat overactive bladder
The company discovers, develops, manufactures, and markets a broad range of healthcare therapies.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd